BM
CELG

Bill Miller’s Celgene Corp CELG Stock Holding History

Bill Miller’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-423,255
Closed -$39.9M – 117
2019
Q1 		$39.9M Sell
423,255
-412,940
-49% -$36.1M 1.58% 29
2018
Q4 		$53.6M Buy
836,195
+4,250
+0.5% +$314K 2.43% 19
2018
Q3 		$74.5M Buy
831,945
+133,040
+19% +$11.8M 2.4% 18
2018
Q2 		$55.5M Buy
698,905
+284,850
+69% +$23.7M 2.07% 24
2018
Q1 		$36.9M Buy
414,055
+411,855
+18,721% +$39.5M 1.54% 30
2017
Q4 		$230K Hold
2,200
– – 0.01% 103
2017
Q3 		$321K Hold
2,200
– – 0.01% 102
2017
Q2 		$286K Buy
+2,200
New +$270K 0.01% 103

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Bill Miller's CELG Position: Q2 2019 in Review

Bill Miller sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 423,255 shares — an estimated $39.9M sold.

Bill Miller first reported a position in CELG in Q2 2017 and held it in 8 quarters. The position peaked at $74.5M in Q3 2018. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Bill Miller reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Bill Miller sold 423,255 Celgene Corp shares in Q2 2019, an estimated $39.9M.
  • Bill Miller first reported a position in Celgene Corp in Q2 2017 and held it in 8 quarters.
  • Bill Miller's Celgene Corp position peaked at $74.5M in Q3 2018.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Miller Value Partners's 13F filing for Q2 2019, filed 14 Aug 2019.